MedPath

Effect of a Stress Reduction and Lifestyle Modification Programme on the Quality of Life of Crohn's Disease Patients

Not Applicable
Completed
Conditions
Crohn Disease
Interventions
Behavioral: lifestyle-modification
Behavioral: waiting control group
Registration Number
NCT05182645
Lead Sponsor
Jost Langhorst
Brief Summary

Patients with crohn's disease often suffer significant limitations to their quality of life, which are also conditioned by particular stress and psychosocial accompanying symptoms of the disease. A multimodal program for stress-reduction and lifestyle-modification has been shown to be effective in promoting the quality of life in patients with uncreative colitis. The study will examine the promotion of the quality of life of patients with crohn's disease and the positive Influence on stress, psychological symptoms and physiological parameters.

Detailed Description

40 patients with ulcerative colitis will be randomized in an Intervention group and a control group for 10 weeks. The primary outcome is the feasibility of the study, the intervention and the examinations. The Secondary outcomes are disease-specific quality of life, disease-activity, stress, psychological symptoms, inflammatory parameters, disease activity parameters, bowel parameter and the microbiome. As qualitative parameters, the influence of the disease on everyday life and the experience/ impact/ implementability of the programme will be investigated. Lastly, undesirable events will be recorded.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • age between 18 and 75 years
  • Presence of a confirmed diagnosis of Crohn's disease
  • In remission (not longer than 12 months, or mild to moderate clinical activity (HBI < 16)
  • Medication that has been stable for at least 3 months, regardless of whether glucocorticoids, immunosuppressive drugs, azathioprine, or other drug treatments according to MBMCrohn - Version 1.0 from 06.12.2019 Page 7 Guideline
  • Signed declaration of consent
Exclusion Criteria
  • infectious or refractory Crohn's disease with severe course
  • Complete colectomy
  • Severe psychological illness (e.g. depression requiring treatment, addiction, schizophrenia)
  • Severe comorbid somatic disease (e.g. diabetes mellitus, oncological disease)
  • Pregnancy
  • Participation in stress reduction programmes or clinical studies on psychological interventions

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
lifestyle-modificationlifestyle-modificationOnce a week for 10 weeks with a circumference of 60 hours with mindfulness-based stress reduction and further process of the Mind / body medicine.
waiting control groupwaiting control groupA unique education unit within the scope of 3 hours on the influence of lifestyle factors on the disease and self-help materials for the independent training. After the follow-up measurement opportunity to participate in the program.
Primary Outcome Measures
NameTimeMethod
Recruitment successweek 48

Proportion of people responding to appeals for studies

Attendanceweek 48

Proportion of people which actually attend the study

Willingness to participateweek 48

Proportion of people which actually agreed in relation to the proportion of people which responded to the appeal.

Loss of participants over the study periodweek 48

Proportion of people who quit during the study

Secondary Outcome Measures
NameTimeMethod
creatininweek 48

Determination of creatin in the blood

(PMN)-elastaseweek 48

Determination of (PMN)-elastase in the stool

Generic quality of life by SF-36week 0

Short Form Health 36 (SF-36) shows health-related quality of life, 36 items in 8 categories, 25% of the items must be filled in per category for evaluation. Lower sum score correlates with lower quality of life; higher sum score correlates with better quality of life.

Generic quality of life by SF 36week 12

Short Form Health 36 (SF-36) shows health-related quality of life, 36 items in 8 categories, 25% of the items must be filled in per category for evaluation. Lower sum score correlates with lower quality of life; higher sum score correlates with better quality of life.

Disease activity 2 by BHIweek 0

Harvey-Bradshaw Index - HBI is used to assess the degree of illness in individuals with Crohn's disease. The highest possible sum is 30 points and indicates a severe course of disease. A lower sum than 5 points indicates a clinical remission.

Coping strategies by COPEweek 48

Coping Orientations to problems experienced Scale (COPE), total values of each scale vary between 2 (minimum) and 8 (maximum). Higher values indicate increased use of the specific coping strategy

lymphocyte (T-cell) profilingweek 36

Determination of lymphocyte (T-cell) profiling in the blood

Flourishing by FS-Dweek 48

Flourishing Scale (FS-D), total value of the scale vary between 8 (minimum) and 56 (maximum). A high value corresponds to a person with many psychological resources and strengths.

Core Self-Evaluation by CSESweek 48

Core Self-Evaluation (CSES), 12 items on five-point Likert scale, 1 indicates disagreement and 5 indicates full agreement. High scores on the CSES represents a positive, confident, and self-efficacious person

alpha-1- antitrypsinweek 12

Determination of alpha-antitrypsin in the stool

intestinal microbiomeweek 36

Determination of intestinal microbiome

Intestinal permeabilityweek 0

confocal laser endomircoscopy

qualitatives Interviewweek 36

guideline oriented qualitative interview about the influence of the disease on the patients' everyday life, experience with the programme offered, effects of the intervention on the disease, implementation of the intervention in everyday life

professional career (questionnaire)week 0

identification of job qualifications

CRP (C-reactive protein)week 48

Determination of CRP in the blood

Generic quality of life by SF36week 48

Short Form Health 36 (SF-36) shows health-related quality of life, 36 items in 8 categories, 25% of the items must be filled in per category for evaluation. Lower sum score correlates with lower quality of life; higher sum score correlates with better quality of life.

Anxiety and depression by HADSweek 48

Hospital Anxiety and Depression Scale (HADS), 14 items (7 each for depressive symptoms or symptoms of anxiety). The two summated scores of the summated scales HADS-A and HADS-D range between 0 and 21. high scores indicate depressivness and anxiety.

Perceived stress by PSSweek 48

Perceived Stress Scale (PSS), Rating on a five-step scale from 1 (= never) to 5 (=very often), high stress is assumed from a total score of 20 points

calprotectinweek 48

Determination of calprotectin in the stool

Human beta-defensin-2 (hBD-2)week 48

Determination of hBD-2 in the stool

prolactin levelsweek 12

Determination of prolactin levels during Trier Social Stress Test at 4 points in time in the afternoon (right before, right after, 10 minutes after and 60 minutes after the Trier Social Stress Test)

heart rateweek 12

Determination of heart rate during Trier Social Stress Test at 4 points in time in the afternoon (right before, right after, 10 minutes after and 60 minutes after the Trier Social Stress Test)

Adverse eventsweek 48

all adverse events

sex (questionnaire)week 0

identification of the gender (male/female)

School career (questionnaire)week 0

identification of the school career

occupation (questionnaire)week 0

identification of the type of occupation

Disease-specific quality of life by IBD-Qweek 48

Inflammatory Bowel Disease Questionnaire (IBD-Q), Recording on 7-point Likert scale, high values mean good, low values a reduced quality of life (1=worst score, 7=best score)

lactoferrinweek 48

Determination of lactoferrin in the stool

cortisolweek 12

Determination of cortisol during Trier Social Stress Test at 4 points in time in the afternoon (right before, right after, 10 minutes after and 60 minutes after the Trier Social Stress Test)

ACTHweek 12

Determination of ACTH during Trier Social Stress Test at 4 points in time in the afternoon (right before, right after, 10 minutes after and 60 minutes after the Trier Social Stress Test)

alpha-1-antitrypsinweek 48

Determination of alpha-antitrypsin in the stool

Disease activity by HBIweek 48

Harvey-Bradshaw Index - HBI is used to assess the degree of illness in individuals with Crohn's disease. The highest possible sum is 30 points and indicates a severe course of disease. A lower sum than 5 points indicates a clinical remission.

BSG (blood cell sedimentation rate)week 48

Determination of BSG in the blood

zonulinweek 48

Determination of zonulin in the stool

glucocorticoid and β-adrenergic regulation of IL-8 and IL-10week 12

Determination of glucocorticoid and β-adrenergic regulation of IL-8 and IL-10 during Trier Social Stress Test at 4 points in time in the afternoon (right before, right after, 10 minutes after and 60 minutes after the Trier Social Stress Test)

TNF-α production by peripheral blood cellsweek 12

Determination of TNF-α production by peripheral blood cells during Trier Social Stress Test at 4 points in time in the afternoon (right before, right after, 10 minutes after and 60 minutes after the Trier Social Stress Test)

blood pressure systolic and diastolicweek 12

Determination of blood pressure (systolic and diastolic) during Trier Social Stress Test at 4 points in time in the afternoon (right before, right after, 10 minutes after and 60 minutes after the Trier Social Stress Test)

STAI-Sweek 12

Determination of STAI-S during Trier Social Stress Test at 4 points in time in the afternoon (right before, right after, 10 minutes after and 60 minutes after the Trier Social Stress Test)

marital status (questionnaire)week 0

identification of the marital status (married/divorced/single/widowed)

age (questionnaire)week 0

age in years

weightweek 0

weight in kilograms

body heightweek 0

body height in meters

job (questionnaire)week 0

identification of the actual job

Trial Locations

Locations (1)

Sozialstiftung Bamberg, Klinik für Intergrative Medizin

🇩🇪

Bamberg, Bayern, Germany

© Copyright 2025. All Rights Reserved by MedPath